Immucor Schedules Second Quarter Earnings Release and Conference Call

NORCROSS, Ga., Dec. 29 Immucor, Inc. (Nasdaq:BLUD), a global leader in providing automated instrument-reagent systems tothe blood transfusion industry, today announced that it expects to release itsfiscal second quarter earnings on Wednesday, January 7, 2009, after the closeof regular trading hours, and then host a conference call on Thursday, January8, 2009 at 8:30 AM (EST) to review the results. Investors are invited toparticipate in this conference call, with Dr. Gioacchino De Chirico, Presidentand Chief Executive Officer, Richard A. Flynt, Chief Financial Officer, andEdward L. Gallup, consultant. The call will focus on the results for thesecond quarter and general business trends. The earnings release will beposted on Immucor's website, as well as any material financial informationthat may be discussed by Dr. De Chirico, Mr. Flynt, or Mr. Gallup during thiscall that is not contained in the earnings release. Both the earnings releaseand the additional financial information, if any, will be posted as soon aspracticable after the call on the investor news section of Immucor's website.To access this information once posted, go to Immucor's website atwww.immucor.com and click on "About Us - Press Releases."

To participate in the telephone conference call, dial 1-888-324-7567 andpasscode BLUD. Replays of the conference call will be available for one weekbeginning at 12:00 noon on January 8th by calling 1-866-457-5510 and passcode2468. Beginning January 15, 2009, audio of the conference call or atranscript of the audio will be available on the "About Us - Press Releases"page of the Immucor website.

For more information on Immucor, please visit our website atwww.immucor.com.

Founded in 1982, Immucor manufactures and sells a complete line ofreagents and systems used by hospitals, reference laboratories and donorcenters to detect and identify certain properties of the cell and serumcomponents of blood prior to transfusion. Immucor markets a complete family ofautomated instrumentation for all of its market segments.

SOURCE Immucor, Inc.

Latest Press Release on General News

Philips Shareholders Approve all Proposals at the AGM 2024

May 7, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shar...

Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterin...

Nicklaus Children's Health System, Philips to Provide Innovative Patient and Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients

April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic c...

Cinesteam® Is a Deodorizing Support Tool for Palliative Care

Palliative Care Is a Comprehensive Approach to Long-Term Patient Care. Caregivers Can Use Cinesteam®'s Secondary Dressings to Improve Quality of Life in Palliative Care Settings. FOR...

Philips Delivers First-quarter Results in Line With 2024 Performance Improvement Plan; Resolves the Respironics Personal Injury and Medical Monitoring Litigation in the Us for USD 1.1 Billion

April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 b...